Johnson Matthey Fine Chemicals supplies efficient and sustainable products and services for companies developing pharmaceuticals, agrochemicals and other fine and speciality chemicals.
Our customers trust us to provide them with expert complex chemistry solutions, optimising chemical processes and accelerating their innovation, and we take pride in surpassing their aims using a combination of deep R&D knowledge, large-scale global capabilities and a portfolio of unique technologies.
As well as this, sustainability is a high priority for Johnson Matthey Fine Chemicals and we have made significant progress in reducing material use and production waste as part of our 2017 Sustainability Programme.
Differentiating Technologies and Facilities
We work collaboratively across eleven global sites spanning Europe, North America and Asia to offer complex chemistry solutions through our network of state-of-the-art R&D, kilo lab, pilot scale and large-scale manufacturing facilities.
With our specialist technologies and capabilities, our customers have access to a substantial toolkit for diverse complex chemistries and we can offer a full spectrum of drug development services, from discovery through to commercial manufacture and product life cycle management.
Four Core Offerings
We collaborate efficiently across our four core offerings, which include: Custom Pharma Solutions, Controlled Substances, Catalysts, APIs & Life Cycle Management to provide our customers with a broad range of specialised services to help them develop complex and niche molecules. Through these offerings, we ensure your goals aren’t just met, they are surpassed.
1. Custom Pharma Solutions
Our custom pharma solutions offering provides a full range of bespoke drug development, scale-up and manufacturing services, from pre-clinical and toxicological studies to development and commercial manufacturing. Through this offering, our expert teams focus on understanding your business so that we can solve your most challenging chemistries and scale-up problems.
2. Controlled Substances
Johnson Matthey Fine Chemicals products are extensively used in therapeutic areas including analgesia, CNS disorders and anti-addiction treatments. We have deep expertise in handling complex APIs and potent products, spending over 200 years building our extensive range of opiates and controlled substances. Through our state-of-the-art facilities and GMP-compliant bulk production plants we have the knowledge to overcome the most challenging chemistries and complex paperwork, ensuring the reliable supply of controlled substance APIs to our customers.
Our catalysts offering includes a broad portfolio of heterogeneous and homogeneous catalysts, chiral catalysts and a range of biocatalysts that can be applied to accelerate reactions and optimise your processes. Our advanced catalysts help to make your chemistry more efficient, selective and sustainable as well as reducing cost, process steps and waste in the process.
4. APIs & Life Cycle Management
We provide an extensive range of APIs and the invaluable expertise to develop many more. We are particularly knowledgeable in platinum-based actives and prostaglandins as well as products covering a wide range of therapeutic classes such as anti-cancer, anti-rheumatic, addiction, psychiatric disorders and ophthalmic indications, however we are continually seeking to expand and increase our API portfolio through collaborative working.
Johnson Matthey Fine Chemicals believes that combining innovative business models with collaborative process development helps to strengthen your products, while reducing your risk.